Clover Health Investments (NASDAQ:CLOV) Research Coverage Started at Craig Hallum

Craig Hallum initiated coverage on shares of Clover Health Investments (NASDAQ:CLOV) in a research report sent to investors on Tuesday, MarketBeat Ratings reports. The firm issued a buy rating and a $6.00 price target on the stock.

Separately, UBS Group started coverage on Clover Health Investments in a research note on Monday, October 7th. They issued a “neutral” rating and a $4.00 price objective on the stock.

Clover Health Investments Trading Up 1.3 %

Shares of CLOV stock opened at $3.19 on Tuesday. Clover Health Investments has a 12 month low of $0.61 and a 12 month high of $4.71. The firm has a market capitalization of $1.60 billion, a PE ratio of -15.95 and a beta of 1.94. The firm has a fifty day simple moving average of $3.60 and a two-hundred day simple moving average of $2.66.

Clover Health Investments (NASDAQ:CLOV) last announced its earnings results on Wednesday, November 6th. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.03) by $0.01. The company had revenue of $330.99 million during the quarter, compared to the consensus estimate of $347.60 million. Clover Health Investments had a negative net margin of 5.92% and a negative return on equity of 25.46%. During the same quarter in the prior year, the company posted ($0.09) earnings per share. On average, equities analysts predict that Clover Health Investments will post -0.12 earnings per share for the current fiscal year.

Institutional Trading of Clover Health Investments

A number of hedge funds and other institutional investors have recently bought and sold shares of CLOV. Geode Capital Management LLC boosted its position in shares of Clover Health Investments by 21.9% during the 3rd quarter. Geode Capital Management LLC now owns 4,828,701 shares of the company’s stock valued at $13,622,000 after acquiring an additional 868,501 shares during the last quarter. State Street Corp raised its stake in Clover Health Investments by 65.0% in the third quarter. State Street Corp now owns 2,189,380 shares of the company’s stock valued at $6,174,000 after purchasing an additional 862,621 shares in the last quarter. XTX Topco Ltd bought a new stake in Clover Health Investments during the second quarter valued at approximately $932,000. Connor Clark & Lunn Investment Management Ltd. grew its stake in Clover Health Investments by 75.7% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,128,171 shares of the company’s stock worth $3,181,000 after buying an additional 485,987 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in shares of Clover Health Investments in the 3rd quarter worth $1,228,000. Institutional investors own 19.77% of the company’s stock.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.